Related Experiment Video
Updated: Apr 6, 2026
10:31
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
825
Molecular disease presentation in diabetic nephropathy
Andreas Heinzel1, Irmgard Mühlberger1, Gil Stelzer2
1emergentec biodevelopment GmbH, Vienna, Austria.
Summary
Diabetic nephropathy (DN) is a growing kidney disease. This review explores omics studies to find new therapeutic targets by integrating genomic, transcriptomic, proteomic, and metabolomic data.
Area of Science:
- Nephrology
- Molecular Biology
- Genomics
- Proteomics
- Metabolomics
Background:
- Diabetic nephropathy (DN) is the leading cause of end-stage renal disease, with rising incidence in type 2 diabetes.
- Current treatments target the renin-angiotensin-aldosterone system, but novel therapeutics are needed.
- Understanding early molecular changes is crucial for developing effective treatments for DN.
Purpose of the Study:
- To review key omics studies (genome, transcriptome, proteome, metabolome) in diabetic nephropathy.
- To present concepts for integrating multi-omics data for a comprehensive understanding of DN.
- To identify potential molecular targets for novel DN therapeutics.
Main Methods:
- Systematic review of high-throughput omics studies in DN.
- Analysis of genomic, transcriptomic, proteomic, and metabolomic data.
- Integration of multi-omics findings using gene ontology, pathway analysis, and protein-protein interaction networks.
Main Results:
- Omics studies have identified numerous deregulated molecules in DN.
- Integration of multi-omics data reveals complex molecular pathways and processes involved in DN.
- Phenotype molecular models can be constructed from integrated omics data.
Conclusions:
- Multi-omics approaches provide a systems-level understanding of diabetic nephropathy.
- Integrating diverse omics data is key to uncovering novel therapeutic strategies for DN.
- Further research integrating omics data will advance the development of targeted DN therapies.
Related Concept Videos
01:20Pathophysiology of Diabetes
4.5K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.5K
01:25Chronic Kidney Disease I: Introduction
1.2K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.8K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.8K
01:22Diabetes Mellitus: Overview and Type I Subtype
6.1K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.1K
01:22Diabetes Mellitus: Type 2 and Gestational
5.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.6K
01:24Nephrotic Syndrome I : Introduction
1000
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1000